Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
Open Access
- 15 April 2011
- journal article
- Published by Springer Nature in Virology Journal
- Vol. 8 (1) , 170
Abstract
Background: In this study, porcine encephalomyocarditis virus (EMCV) virus-like particles (VLPs) were generated using a baculovirus expression system and were tested for immunogenicity and protective efficacy in vivo. Results: VLPs were successfully generated from Sf9 cells infected with recombinant baculovirus and were confirmed to be approximately 30-40 nm by transmission electron microscopy (TEM). Immunization of mice with 0.5 μg crude protein containing the VLPs resulted in significant protection from EMCV infection (90%). In swine, increased neutralizing antibody titers were observed following twice immunization with 2.0 μg crude protein containing VLPs. In addition, high levels of neutralizing antibodies (from 64 to 512 fold) were maintained during a test period following the second immunization. No severe injection site reactions were observed after immunization and all swine were healthy during the immunization period Conclusion: Recombinant EMCV VLPs could represent a new vaccine candidate to protect against EMCV infection in pig farms.Keywords
This publication has 31 references indexed in Scilit:
- Encephalomyocarditis in Korea: Serological survey in pigs and phylogenetic analysis of two historical isolatesVeterinary Microbiology, 2009
- Protective Immune Responses against Foot-and-Mouth Disease Virus by Vaccination with a DNA Vaccine Expressing Virus-Like ParticlesViral Immunology, 2007
- A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failureVaccine, 2006
- Pathogenesis of encephalomyocarditis experimental infection in young piglets: a potential animal model to study viral myocarditisVeterinary Research, 2006
- Noninfectious Virus-Like Particle Antigen for Detection of Swine Vesicular Disease Virus Antibodies in Pigs by Enzyme-Linked Immunosorbent AssayClinical and Vaccine Immunology, 2005
- SEROLOGIC RESPONSES OF BARBARY SHEEP (AMMOTRAGUS LERVIA), INDIAN ANTELOPE (ANTILOPE CERVICAPRA), WALLAROOS (MACROPUS ROBUSTUS), AND CHIMPANZEES (PAN TROGLODYTES) TO AN INACTIVATED ENCEPHALOMYOCARDITIS VIRUS VACCINEJournal of Zoo and Wildlife Medicine, 2005
- Efficient assembly and release of SARS coronavirus‐like particles by a heterologous expression systemFEBS Letters, 2004
- Priming of Strong, Broad, and Long-Lived HIV Type 1 p55 gag -Specific CD8 + Cytotoxic T Cells after Administration of a Virus-Like Particle Vaccine in Rhesus MacaquesAIDS Research and Human Retroviruses, 2000
- Engineering parvovirus-like particles for the induction of B-cell, CD4+ and CTL responsesVaccine, 1999
- Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virusVaccine, 1996